Back to top

Company News For Dec 14, 2017

Read MoreHide Full Article
  • Shares of Civitas Solutions Inc (CIVI - Free Report) declined 10% after reporting fourth quarter 2017 revenues of $380 million, lower than the Zacks Consensus Estimate of $388 million
  • Cellectis S.A.’s (CLLS - Free Report) shares gained 11.6% after reporting positive results from 2 acute lymphoblastic leukemia trials of Servier and Pfizer's UCART19 product
  • Shares of VeriFone Systems, Inc. declined 3.8% after the company issued FY 2018 EPS guidance in the range of $1.47-$1.50 per share, lower than the Zacks Consensus Estimate of $1.57
  • Finisar Corporation’s (FNSR - Free Report) gained 22.8% after the company announced that it would receive a $390 million award from Apple (AAPL - Free Report)

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Apple Inc. (AAPL) - free report >>

Finisar Corporation (FNSR) - free report >>

Cellectis S.A. (CLLS) - free report >>

Civitas Solutions, Inc. (CIVI) - free report >>

More from Zacks Corporate Summary

You May Like